Medical Center VAS OOD
- Address
- Ulitsa Nikola Simov 11, 7703 Targovishte, Bulgaria
Medical Center VAS OOD - Psychiatric Disorders Research Center
Medical Center VAS OOD is a specialized clinical research facility focused on advancing treatment options for patients with psychiatric and mental health disorders. The center demonstrates particular expertise in conducting phase II and III clinical trials for novel therapeutic agents targeting anxiety disorders and psychotic conditions, with a strong emphasis on evaluating both efficacy and long-term safety outcomes.
- Generalized Anxiety Disorder (GAD) treatment studies, including monotherapy and adjunctive therapy approaches
- Schizophrenia symptom management and novel antipsychotic agent evaluation
- Long-term safety and tolerability assessments for psychiatric medications
The center's research portfolio includes comprehensive evaluation of ITI-1284 for Generalized Anxiety Disorder and KarXT for schizophrenia, utilizing validated assessment tools such as the Hamilton Anxiety Rating Scale (HAM-A) and Positive and Negative Syndrome Scale (PANSS). Medical Center VAS OOD is committed to supporting patients with inadequately controlled psychiatric symptoms through innovative clinical research, offering access to emerging therapeutic options while maintaining rigorous safety monitoring protocols and long-term follow-up studies.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Intra-Cellular Therapies Inc.2active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Intra-Cellular Therapies Inc.2trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 476 other sites in Bulgaria
Therapeutic Area Benchmark — Bulgaria
Select a therapeutic area to compare against other sites in Bulgaria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Bulgaria
Market Share
Country: Bulgaria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Medical Center VAS OOD
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of ITI-1284 as Adjunctive Therapy in Generalized Anxiety Disorder Patients with Inadequate Response to Standard Treatment | Intra-Cellular Therapies Inc. | Phase II | Recruiting | Nov 2025 | — |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Iti-1284 | 2 | Unknown | 2025-07-21 | 2025-11-17 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.